Search Results 421-430 of 17022 for pharmacogenetics

  1. Lenalidomide And Dexamethasone With Or Without Bortezomib In Treating Patients With Previously Untreated Multiple Myeloma - Mayo Clinic

    Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, ...

  2. Patient Resources - Mayo Clinic Research

    View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.

  3. Medical Research & Education - Mayo Clinic News Network

    The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...

  4. Education and training - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    The Biliary Epigenetics and Regenerative Medicine Laboratory of Robert C. Huebert, M.D., at Mayo Clinic provides training, education and career ...

  5. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors ...

  6. A Study to Evaluate a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis - Mayo Clinic

    The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...

  7. Friedreich's Ataxia Clinical Trials - Mayo Clinic Research

    The primary purpose of this dose-ranging study is to assess the safety and tolerability of 3 ascending doses of LX2006 gene therapy for the purpose of selecting ...

  8. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...

  9. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

    The purpose of this study is to compare the effectiveness of temozolomide to selumetinib for the treatment of patients who have melanoma of the eye that has ...

  10. Individualized Medicine for Cardiomyopathies - Zebrafish Genetics Lab: Xiaolei Xu - Mayo Clinic Research

    Mayo Clinic's Zebrafish Genetics Lab led by Xiaolei Xu, Ph.D., is discovering genes that help develop individualized medicine for idiopathic dilated ...